Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

TransMedics Group, Inc. TMDX

Set alert

Price alert · TMDX

All alert types
66.67 USD +0.68 +1.03%

At close · Nov 2

66.67 0.00 0.00%

After hours · Nov 2, 4:00 PM ET

Bid
66.53 × 2
Ask
66.69 × 2
65.84 Day range 68.66
60.11 52-week range 156.00
YTD
-45.20%
1 year
-49.32%
Open
66.47
Prev close
65.99
Mkt cap
2.30B
Vol
689.58K
Avg vol
837.49K
EPS
3.90
P/E
17.09
Div yield
0.00%
More statistics
Low
65.84
High
68.66
Forward P/E
29.58
Beta
2.10
Short ratio
11.14
Inst. own
104.51%
Dividend
0.00
Ex-div date
Earnings
Nov 5, 2026
50-d avg
81.65
200-d avg
94.48
1y target
98.73

MAX chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • Jul 30, 2025Earnings: 0.92; estimate 0.48; surprise 91.67%
  • Oct 29, 2025Earnings: 0.66; estimate 0.37; surprise 78.38%
  • Feb 24, 2026Earnings: 0.57; estimate 0.41; surprise 39.02%
  • May 5, 2026Earnings: 0.3; estimate 0.62; surprise -51.61%
  • Aug 3, 2026Rating: Needham · Buy → Buy
  • Aug 4, 2026Earnings: 0.44; estimate 0.4955; surprise -11.2%
  • Aug 5, 2026Rating: Piper Sandler · Overweight → Overweight
  • Aug 5, 2026Rating: UBS · Neutral → Neutral
  • Sep 8, 2026Rating: TD Cowen · Buy → Buy
  • Oct 7, 2026Rating: Barclays · — → Overweight
  • Oct 13, 2026Rating: Canaccord Genuity · Buy → Buy
  • Nov 5, 2026Earnings: —; estimate 0.2976; surprise —%
Signals (145)
NameDateAgo
MACD: Sell SignalOct 26, 20261 week ago
SMA: BearishSep 28, 20261 month ago
MACD: Buy SignalJul 27, 20263 months ago
SMA: BullishJul 6, 20264 months ago
RSI: OversoldMay 11, 20265 months ago
SMA: BearishMar 9, 20267 months ago
SMA: BearishMar 2, 20268 months ago
MACD: Sell SignalMar 2, 20268 months ago
MACD: Buy SignalFeb 23, 20268 months ago
SMA: BullishFeb 16, 20268 months ago
SMA: BearishFeb 9, 20268 months ago
MACD: Sell SignalFeb 9, 20268 months ago
MACD: Buy SignalJan 12, 20269 months ago
SMA: BullishJan 5, 202610 months ago
MACD: Sell SignalDec 22, 202510 months ago
SMA: BearishDec 15, 202510 months ago
SMA: BullishNov 17, 202511 months ago
SMA: BullishNov 17, 202511 months ago
MACD: Buy SignalNov 17, 202511 months ago
SMA: BearishNov 10, 202511 months ago

Newest 20 of 145.

Financial health

Altman Z-Score

2.34 Grey zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B3 / 5 overall

  • DCF 1
  • Return on Equity 5
  • Return on Assets 5
  • Debt / Equity 1
  • P/E 3
  • P/B 2

Valuation

P/E 21.7×
FY 2016: -13.5×FY 2017: -15.5×FY 2018: -18.2×FY 2019: -8.1×FY 2020: -17.2×FY 2021: -12.0×FY 2022: -50.2×FY 2023: -103×FY 2024: 58.3×FY 2025: 21.7×
FY 2016 5y median -12.0× FY 2025
P/S 6.8×
FY 2016: 52.1×FY 2017: 42.1×FY 2018: 33.1×FY 2019: 11.4×FY 2020: 19.2×FY 2021: 17.5×FY 2022: 19.5×FY 2023: 10.6×FY 2024: 4.7×FY 2025: 6.8×
FY 2016 5y median 10.6× FY 2025
P/B 8.7×
FY 2016: 8.3×FY 2017: -1.9×FY 2018: -89.2×FY 2019: 4.9×FY 2020: 4.7×FY 2021: 7.8×FY 2022: 9.7×FY 2023: 18.7×FY 2024: 9.1×FY 2025: 8.7×
FY 2016 5y median 9.1× FY 2025
P/FCF 31.0×
FY 2016: -12.7×FY 2017: -13.9×FY 2018: -16.3×FY 2019: -8.3×FY 2020: -16.0×FY 2021: -16.3×FY 2022: -31.6×FY 2023: -13.4×FY 2024: -25.6×FY 2025: 31.0×
FY 2016 5y median -16.3× FY 2025
EV/EBITDA 27.7×
FY 2016: -14.2×FY 2017: -16.8×FY 2018: -21.9×FY 2019: -10.2×FY 2020: -21.7×FY 2021: -14.2×FY 2022: -58.4×FY 2023: -349×FY 2024: 32.2×FY 2025: 27.7×
FY 2016 5y median -14.2× FY 2025
EV/Sales 6.8×
FY 2016: 51.9×FY 2017: 41.7×FY 2018: 34.1×FY 2019: 12.0×FY 2020: 19.6×FY 2021: 18.1×FY 2022: 18.1×FY 2023: 11.1×FY 2024: 5.1×FY 2025: 6.8×
FY 2016 5y median 11.1× FY 2025
FCF Yield 3.2%
FY 2016: -7.9%FY 2017: -7.2%FY 2018: -6.1%FY 2019: -12.0%FY 2020: -6.2%FY 2021: -6.1%FY 2022: -3.2%FY 2023: -7.5%FY 2024: -3.9%FY 2025: 3.2%
FY 2016 5y median -3.9% FY 2025

Profitability

Gross Margin 59.9%
FY 2016: 12.3%FY 2017: 27.8%FY 2018: 44.1%FY 2019: 58.7%FY 2020: 64.9%FY 2021: 69.9%FY 2022: 69.8%FY 2023: 63.8%FY 2024: 59.4%FY 2025: 59.9%
FY 2016 5y median 63.8% FY 2025
Operating Margin 17.9%
FY 2016: -370.2%FY 2017: -265.8%FY 2018: -155.5%FY 2019: -125.4%FY 2020: -102.9%FY 2021: -130.3%FY 2022: -33.6%FY 2023: -11.9%FY 2024: 8.5%FY 2025: 17.9%
FY 2016 5y median -11.9% FY 2025
Net Margin 31.4%
FY 2016: -387.6%FY 2017: -271.0%FY 2018: -182.5%FY 2019: -142.1%FY 2020: -112.1%FY 2021: -146.1%FY 2022: -38.8%FY 2023: -10.4%FY 2024: 8.0%FY 2025: 31.4%
FY 2016 5y median -10.4% FY 2025
ROE 40.2%
FY 2016: -62.0%FY 2017: 12.3%FY 2018: 492.4%FY 2019: -61.4%FY 2020: -27.7%FY 2021: -65.2%FY 2022: -19.3%FY 2023: -18.2%FY 2024: 15.5%FY 2025: 40.2%
FY 2016 5y median -18.2% FY 2025
ROIC 10.9%
FY 2016: -47.3%FY 2017: -73.2%FY 2018: -68.4%FY 2019: -33.2%FY 2020: -18.8%FY 2021: -35.3%FY 2022: -12.3%FY 2023: -4.1%FY 2024: 5.0%FY 2025: 10.9%
FY 2016 5y median -4.1% FY 2025
ROA 17.8%
FY 2016: -41.4%FY 2017: -56.3%FY 2018: -56.4%FY 2019: -31.9%FY 2020: -18.9%FY 2021: -32.8%FY 2022: -13.1%FY 2023: -3.5%FY 2024: 4.4%FY 2025: 17.8%
FY 2016 5y median -3.5% FY 2025

Growth (YoY)

Revenue 37.1%
FY 2016: 0.0%FY 2017: 23.8%FY 2018: 69.4%FY 2019: 81.3%FY 2020: 8.6%FY 2021: 18.0%FY 2022: 208.8%FY 2023: 158.5%FY 2024: 82.7%FY 2025: 37.1%
FY 2016 FY 2025
Operating Income 189.6%
FY 2016: 0.0%FY 2017: 11.1%FY 2018: 0.9%FY 2019: -46.3%FY 2020: 10.9%FY 2021: -49.4%FY 2022: 20.3%FY 2023: 8.6%FY 2024: 230.5%FY 2025: 189.6%
FY 2016 FY 2025
EPS (diluted) 382.2%
FY 2016: 0.0%FY 2017: 13.3%FY 2018: 14.6%FY 2019: -91.9%FY 2020: 50.8%FY 2021: -37.9%FY 2022: 23.1%FY 2023: 37.4%FY 2024: 231.2%FY 2025: 382.2%
FY 2016 FY 2025
Free Cash Flow 265.0%
FY 2016: 0.0%FY 2017: 8.7%FY 2018: -13.0%FY 2019: -22.9%FY 2020: 5.3%FY 2021: -5.4%FY 2022: -78.3%FY 2023: -232.8%FY 2024: 57.9%FY 2025: 265.0%
FY 2016 FY 2025

Financial Health

Current Ratio 7.1×
FY 2016: 5.9×FY 2017: 3.1×FY 2018: 2.8×FY 2019: 6.2×FY 2020: 12.4×FY 2021: 5.1×FY 2022: 10.7×FY 2023: 9.3×FY 2024: 8.3×FY 2025: 7.1×
FY 2016 5y median 8.3× FY 2025
Quick Ratio 6.6×
FY 2016: 5.2×FY 2017: 2.4×FY 2018: 2.0×FY 2019: 5.5×FY 2020: 11.4×FY 2021: 4.5×FY 2022: 9.8×FY 2023: 8.5×FY 2024: 7.5×FY 2025: 6.6×
FY 2016 5y median 7.5× FY 2025
Debt / Equity 1.0×
FY 2016: 0.2×FY 2017: -0.1×FY 2018: -7.0×FY 2019: 0.6×FY 2020: 0.3×FY 2021: 0.6×FY 2022: 0.4×FY 2023: 3.8×FY 2024: 2.3×FY 2025: 1.0×
FY 2016 5y median 1.0× FY 2025
Net Debt / EBITDA -0.1×
FY 2016: 0.1×FY 2017: 0.2×FY 2018: -0.7×FY 2019: -0.5×FY 2020: -0.4×FY 2021: -0.5×FY 2022: 4.6×FY 2023: -15.7×FY 2024: 2.6×FY 2025: -0.1×
FY 2016 5y median -0.1× FY 2025
Interest Coverage 7.9×
FY 2016: -23.5×FY 2017: -19.1×FY 2018: -8.4×FY 2019: -6.8×FY 2020: -6.6×FY 2021: -10.2×FY 2022: -8.4×FY 2023: -2.7×FY 2024: 2.6×FY 2025: 7.9×
FY 2016 5y median -2.7× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31